

Cover Story
The White House budget blueprint to slash NIH funding by 18.3 percent in fiscal 2018 is just a proposal, NCI Acting Director Douglas Lowy said at the meeting of the Board of Scientific Advisors March 21.
In Brief


Drugs & Targets
Trending Stories
- Trump backs off the 100% pharma tariffs ultimatum
- ASCO and Google Cloud set forth a vision for using AI to modernize health care and advance oncology
- KRAS pioneer and Stephenson Prize winner Frank McCormick aims to prevent all KRAS cancers with a pill
- White House announces “TrumpRx,” a new prescription drug website
- Pulitzer-winning healthcare reporter Laurie McGinley on her shift to advocacy work with PACR
- The Directors: Steven Artandi and Eric Winer on how looming policy changes “reverberate” through oncology
“Even when funding gets restored and if the H-1B visa threat doesn’t materialize, it creates an environment where especially young people become uncertain.”